Evidence map›Paper›PMID 38796802›Full record

ArticleOdontology2025

The existence of cells exhibiting characteristics of both Type II and Type III cells in rat taste buds. An immunohistochemical and electron-microscopic study.

Shuhei Inoko, Hiroki Katagiri, Maiko Tsujimura, Sumio Yoshie

Abstract read
PubMed Publisher
In one paragraph

Article in Odontology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shuhei InokoHistology, The Nippon Dental University Graduate School of Life Dentistry at Niigata, 1-8 Hamaura-Cho, Chuo-Ku, Niigata, 951-8580, Japan.
Hiroki KatagiriDepartment of Histology, The Nippon Dental University School of Life Dentistry at Niigata, 1-8 Hamaura-Cho, Chuo-Ku, Niigata, 951-8580, Japan.
Maiko TsujimuraHistology, The Nippon Dental University Graduate School of Life Dentistry at Niigata, 1-8 Hamaura-Cho, Chuo-Ku, Niigata, 951-8580, Japan. h-maiko@ngt.ndu.ac.jp.ORCID http://orcid.org/0000-0001-8985-3015
Sumio YoshieDepartment of Histology, The Nippon Dental University School of Life Dentistry at Niigata, 1-8 Hamaura-Cho, Chuo-Ku, Niigata, 951-8580, Japan. yoshie@ngt.ndu.ac.jp.

Funding

JSPS KAKENHI 20K10020
6 · The paper itself

Abstract

Taste bud cells are classified into four types by their ultrastructural features. Immunohistochemical detection of taste-signaling molecules is used to distinguish cell types of taste bud cells; however, the characteristics of taste cell types such as the immunoreactivity for taste-signaling molecules have long remained unclear. We investigated the detailed characteristics of taste cells in rat vallate taste buds by electron microscopy and immunohistochemistry for gustducin, neural cell adhesion molecule (NCAM) and vesicle-associated membrane protein 2 (VAMP2), which are known as markers of Type II cells, Type III cells and both cell types, respectively. Triple immunostaining for these molecules discriminated seven kinds of cell, including the totally immunopositive cell. Electron microscopy revealed Type III cells with a typical synaptic structure and subsurface cisterna as a specialized contact between a nerve and a Type II cell. The present study clarified the existence of cells with features of both Type II and Type III cells as a subtype of taste bud cells in the rat taste bud.

Indexed as

ImmunohistochemistryRats, WistarTaste BudsTransducinAnimalsMaleMicroscopy, ElectronMicroscopy, Electron, TransmissionNeural Cell Adhesion MoleculesRatsgustducinNeural Cell Adhesion MoleculesTransducinCell typeElectron microscopyImmunohistochemistryRatTaste bud

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.